Divi's Laboratories Limited (BOM:532488)

Market Cap	1.61T
Revenue (ttm)	100.29B
Net Income (ttm)	24.85B
Shares Out	n/a
EPS (ttm)	93.59
PE Ratio	64.86
Forward PE	55.96
Dividend	30.00 (0.48%)
Ex-Dividend Date	Jul 25, 2025

Volume	2,154
Average Volume	9,081
Open	6,038.45
Previous Close	6,002.85
Day's Range	6,031.00 - 6,135.50
52-Week Range	4,941.70 - 7,077.70
Beta	n/a
RSI	34.68
Earnings Date	Feb 2, 2026

About Divi's Laboratories

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as lutein and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its pro...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1990
• Employees: 10,542
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532488

Financial Performance

In 2024, Divi's Laboratories's revenue was 93.60 billion, an increase of 19.31% compared to the previous year's 78.45 billion. Earnings were 21.91 billion, an increase of 36.94%.